UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Parallel Computing for Brain Simulation

Current topics in medicinal chemistry, 2017-05, Vol.17 (14), p.1646-1668

2017

Volltextzugriff (PDF)

Electrochemical generation of surface enhanced Raman scattering substrates for the determination of folic acid

Journal of electroanalytical chemistry (Lausanne, Switzerland), 2021-09, Vol.896, p.115288, Article 115288

2021

Volltextzugriff (PDF)

EPAC-lung: pooled analysis of circulating tumour cells in advanced non-small cell lung cancer

European journal of cancer (1990), 2019-08, Vol.117, p.60-68

2019

Volltextzugriff (PDF)

miRNAs in liquid biopsy for oral squamous cell carcinoma diagnosis: Systematic review and meta-analysis

Oral oncology, 2019-12, Vol.99, p.104465-104465, Article 104465

2019

Volltextzugriff (PDF)

Immunotherapy in patients with brain metastasis: advances and challenges for the treatment and the application of circulating biomarkers

Frontiers in immunology, 2023, Vol.14, p.1221113-1221113

2023

Volltextzugriff (PDF)

EPAC-Lung: Pooled analysis of circulating tumor cells in advanced non-small cell lung cancer

Annals of oncology, 2019-04, Vol.30, p.ii7-ii7

2019

Volltextzugriff (PDF)

ETV5 cooperates with LPP as a sensor of extracellular signals and promotes EMT in endometrial carcinomas

Oncogene, 2012-11, Vol.31 (45), p.4778-4788

2012

Volltextzugriff (PDF)

α(1,6)Fucosyltransferase expression is an independent prognostic factor for disease-free survival in colorectal carcinoma

Human pathology, 2011-11, Vol.42 (11), p.1740-1750

2011

Volltextzugriff (PDF)

Tumor invasion and oxidative stress: biomarkers and therapeutic strategies

Current molecular medicine, 2012-07, Vol.12 (6), p.746-762

2012

Volltextzugriff (PDF)

978: A multimarker panel for circulating tumor cells detection predicts patient outcome and therapy response in metastatic colorectal cancer

European journal of cancer (1990), 2014-07, Vol.50, p.S238-S238

2014

Volltextzugriff (PDF)

764 Molecular Characterisation of Circulating Tumor Cells in Human Metastatic Colorectal Cancer

European journal of cancer (1990), 2012-07, Vol.48, p.S181-S181

2012

Volltextzugriff (PDF)

α(1,2)fucosylation in human colorectal carcinoma

Oncology letters, 2010-03, Vol.1 (2), p.361-366

2010

Volltextzugriff (PDF)

Cáncer de pulmón y biopsia líquida: realidades y retos en la práctica clínica

Archivos de bronconeumología, 2019-06, Vol.55 (6), p.289-290

2019

Volltextzugriff (PDF)

437P Designing clinical profiles that influence the discordance of RAS mutations in blood and tissue: Sidedness and anatomical metastasis as factors of disagreement

Annals of oncology, 2020-09, Vol.31, p.S427-S427

2020

Volltextzugriff (PDF)

P-41 Understanding the clinical profiles that influence the concordance of RAS mutations between blood and tissue to guide therapy in metastatic colorectal cancer

Annals of oncology, 2020-07, Vol.31, p.S102-S103

2020

Volltextzugriff (PDF)

1923P - Prognostic value of CTCs in advanced NSCLC patients treated with platinum-based chemotherapy

Annals of oncology, 2019-10, Vol.30, p.v776-v777

2019

Volltextzugriff (PDF)

1923PPrognostic value of CTCs in advanced NSCLC patients treated with platinum-based chemotherapy

Annals of oncology, 2019-10, Vol.30 (Supplement_5)

2019

Volltextzugriff (PDF)

Prognostic value of CTCs in advanced NSCLC patients treated with platinum-based chemotherapy

Annals of oncology, 2019-10, Vol.30, p.v776-v777

2019

Volltextzugriff (PDF)

98P Liquid biopsy in NSCLC: A promising tool to predict immunotherapy response

ESMO open, 2023-10, Vol.8 (1), p.101908, Article 101908

2023

Volltextzugriff (PDF)

21OEPAC-Lung: Pooled analysis of circulating tumor cells in advanced non-small cell lung cancer

Annals of oncology, 2019-04, Vol.30 (Supplement_2)

2019

Volltextzugriff (PDF)

Monitoring of Circulating Tumor Cells in Patients With High-Risk Nonmetastatic Prostate Cancer Treated With Radiation Therapy and Hormones: Preliminary Data of an Observational Prospective Phase 2 Study

International journal of radiation oncology, biology, physics, 2017-10, Vol.99 (2), p.E280-E280

2017

Volltextzugriff (PDF)

159 TGF-β1 as a therapeutic target in high risk endometrial carcinomas

European journal of cancer supplements, 2010, Vol.8 (7), p.55-56

2010

Volltextzugriff (PDF)

Phase II study of weekly cabazitaxel for ‘unfit’ metastatic castration resistant prostate cancer patients (mCRPC) progressing after docetaxel (D) treatment. Circulating tumour cell (CTC) analysis (SOGUG-CABASEM Trial)

Annals of oncology, 2016-10, Vol.27, p.vi255-vi255

2016

Volltextzugriff (PDF)

Accuracy of plasma RAS mutation testing for therapy selection and monitoring of colorectal cancer patients

Annals of oncology, 2016-10, Vol.27, p.vi176-vi176

2016

Volltextzugriff (PDF)

[alpha](1,6)Fucosyltransferase expression is an independent prognostic factor for disease-free survival in colorectal carcinoma

Human pathology, 2011-11, Vol.42 (11), p.1740

2011

Volltextzugriff (PDF)

1 – 25 von 139

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(118)
Mit Volltextzugriff
(117)

Publikationsform

Sprache

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(2)

Menü

Weitere Dienste

Einstellungen

Parallel Computing for Brain Simulation

Electrochemical generation of surface enhanced Raman scattering substrates for the determination of folic acid

EPAC-lung: pooled analysis of circulating tumour cells in advanced non-small cell lung cancer

miRNAs in liquid biopsy for oral squamous cell carcinoma diagnosis: Systematic review and meta-analysis

Immunotherapy in patients with brain metastasis: advances and challenges for the treatment and the application of circulating biomarkers

EPAC-Lung: Pooled analysis of circulating tumor cells in advanced non-small cell lung cancer

ETV5 cooperates with LPP as a sensor of extracellular signals and promotes EMT in endometrial carcinomas

α(1,6)Fucosyltransferase expression is an independent prognostic factor for disease-free survival in colorectal carcinoma

Tumor invasion and oxidative stress: biomarkers and therapeutic strategies

978: A multimarker panel for circulating tumor cells detection predicts patient outcome and therapy response in metastatic colorectal cancer

764 Molecular Characterisation of Circulating Tumor Cells in Human Metastatic Colorectal Cancer

α(1,2)fucosylation in human colorectal carcinoma

Cáncer de pulmón y biopsia líquida: realidades y retos en la práctica clínica

437P Designing clinical profiles that influence the discordance of RAS mutations in blood and tissue: Sidedness and anatomical metastasis as factors of disagreement

P-41 Understanding the clinical profiles that influence the concordance of RAS mutations between blood and tissue to guide therapy in metastatic colorectal cancer

1923P - Prognostic value of CTCs in advanced NSCLC patients treated with platinum-based chemotherapy

1923PPrognostic value of CTCs in advanced NSCLC patients treated with platinum-based chemotherapy

Prognostic value of CTCs in advanced NSCLC patients treated with platinum-based chemotherapy

98P Liquid biopsy in NSCLC: A promising tool to predict immunotherapy response

21OEPAC-Lung: Pooled analysis of circulating tumor cells in advanced non-small cell lung cancer

Monitoring of Circulating Tumor Cells in Patients With High-Risk Nonmetastatic Prostate Cancer Treated With Radiation Therapy and Hormones: Preliminary Data of an Observational Prospective Phase 2 Study

159 TGF-β1 as a therapeutic target in high risk endometrial carcinomas

Phase II study of weekly cabazitaxel for ‘unfit’ metastatic castration resistant prostate cancer patients (mCRPC) progressing after docetaxel (D) treatment. Circulating tumour cell (CTC) analysis (SOGUG-CABASEM Trial)

Accuracy of plasma RAS mutation testing for therapy selection and monitoring of colorectal cancer patients

[alpha](1,6)Fucosyltransferase expression is an independent prognostic factor for disease-free survival in colorectal carcinoma

Suchergebnisse filtern